Impacts of anticancer drug parity laws on mortality rates

Yichen Shen*, Haruko Noguchi


研究成果: Article査読

1 被引用数 (Scopus)


This study investigates the impacts of anticancer drug parity laws on mortality rates in the United States using a difference-in-differences approach. Using data from 2004 to 2017 Compressed Mortality Files, we show that the anticancer drug parity laws reduce the mortality rate for head/neck malignant cancers but have no impact on malignant cancers of other types. We also rule out an insurance expansion channel that may influence the relationship between anticancer drug parity laws and malignant cancer mortality. Our results are robust to various specifications and falsification tests. Our findings imply that providing equal access to oral anticancer drugs is an effective tool for the prevention of premature mortality.

ジャーナルSocial Science and Medicine
出版ステータスPublished - 2021 3月

ASJC Scopus subject areas

  • 健康(社会科学)
  • 科学史および科学哲学


「Impacts of anticancer drug parity laws on mortality rates」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。